- €227.60m
- €1.61bn
- €121.52m
- 46
- 78
- 14
- 40
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 26.3 | 35.5 | 44.1 | 60.7 | 122 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 16.1 | 21.6 | 21.9 | 28.8 | 36.8 |
Operating Profit | 10.3 | 13.9 | 22.2 | 31.9 | 84.7 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 5.53 | 7.5 | 14.3 | 22.2 | 43.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5.53 | 7.26 | 13.5 | 20.4 | 39.2 |
Net Income Before Extraordinary Items | |||||
Net Income | 5.53 | 7.26 | 13.5 | 20.4 | 39.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 5.53 | 7.26 | 13.5 | 20.4 | 39.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.059 | 0.08 | 0.123 | 0.22 | 0.376 |
Dividends per Share |